<DOC>
	<DOCNO>NCT00004176</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Drugs amifostine may protect normal cell side effect chemotherapy radiation therapy . PURPOSE : Phase II trial study effectiveness amifostine plus chemotherapy radiation therapy treat patient limited-stage small cell lung cancer .</brief_summary>
	<brief_title>Amifostine , Chemotherapy , Radiation Therapy Treating Patients With Limited-Stage Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine incidence duration moderate severe acute esophagitis patient limited stage small cell lung cancer treat amifostine chemoprotection plus chemotherapy radiotherapy . II . Determine tumor response regimen patient . OUTLINE : Course 1 : Patients receive amifostine IV 5 minute daily , follow radiotherapy twice daily Monday Friday 3 week . Patients receive cisplatin IV 30-60 minute day 1 , etoposide IV 1 hour day 1 , 2 , 3 . Courses 2-4 : Patients receive amifostine 15 minute day 1 , follow cisplatin IV 30-60 minute etoposide IV 1 hour every 3 week . Patients follow 1 month , every 3 month death . PROJECTED ACCRUAL : Approximately 33 patient accrue study within 1-2 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Amifostine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm limited stage small cell lung cancer confine one hemithorax Measurable disease No pleural effusion ( ) PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 60100 % Life expectancy : Not specify Hematopoietic : Neutrophil count least 1,500/mm3 Platelet count least 75,000/mm3 Hepatic : Bilirubin great 2.0 mg/dL SGOT alkaline phosphatase great 2 time upper limit normal Renal : Creatinine great 1.5 mg/dL OR Creatinine clearance least 60 mL/min Calcium normal ( 8.910.3 mg/dL ) Cardiovascular : No history congestive heart failure myocardial infarction within past 6 month No uncontrolled unexplained rhythm disturbance symptom unstable ischemic heart disease Other : Not pregnant Fertile patient must use effective contraception No prior concurrent malignancy within past 5 year , except : Basal squamous cell skin cancer Carcinoma situ cervix No concurrent infection No significant uncontrolled hyponatremia No significant concurrent medical psychiatric illness would preclude compliance No antecedent hear loss Afebrile least 3 day unless fever due tumor obstructive pneumonia PRIOR CONCURRENT THERAPY : Biologic therapy : No prior biologic therapy Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy Surgery : Not specify Other : No drug could potentiate nephrotoxicity cisplatin ( e.g. , aminoglycosides lithium )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>limited stage small cell lung cancer</keyword>
	<keyword>drug/agent toxicity tissue/organ</keyword>
	<keyword>radiation toxicity</keyword>
</DOC>